A detailed history of Gamma Investing LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 1,466 shares of FLGT stock, worth $26,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,466
Previous 1,165 25.84%
Holding current value
$26,197
Previous $22.9 Million 39.37%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$19.6 - $25.06 $5,899 - $7,543
301 Added 25.84%
1,466 $31.9 Million
Q2 2024

Jul 02, 2024

BUY
$19.09 - $22.57 $14,852 - $17,559
778 Added 201.03%
1,165 $22.9 Million
Q1 2024

Apr 05, 2024

SELL
$21.55 - $29.29 $905 - $1,230
-42 Reduced 9.79%
387 $8.4 Million
Q4 2023

Feb 01, 2024

BUY
$23.64 - $30.27 $10,141 - $12,985
429 New
429 $10.5 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.